Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm) Posted: Thursday, September 21, 2006

The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone Arm) Posted: Thursday, September 21, 2006

The results of a major study released: The Dream Study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) with over 5000 patients Rosiglitazone reduced the risk of developing type 2 diabetes by 62 percent (p<0.0001) relative to placebo among people at high risk of developing type 2 diabetes.

Progression Of Diabetic Retinopathy Among African-Americans With Diabetes Posted: Thursday, September 21, 2006

In a six-year study of African Americans with type 1 diabetes, progression of diabetes-related eye disease was high and related to poor blood glucose control and high blood pressure, according to an article in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study Posted: Thursday, September 21, 2006

New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

New Hypertension Pills Cut Diabetes Risk by A Third Posted: Thursday, September 21, 2006

Researchers have reported that patients given a specific combination of new blood pressure drugs are one-third less likely to develop diabetes than those on older pills.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies Posted: Thursday, September 21, 2006

Galvus dropped A1c by 1.8% without weight gain.

New Breakthrough In Fight To Combat Diabetes Posted: Wednesday, September 13, 2006

Researchers have made a breakthrough which could eventually help prevent people developing diabetes.

Overweight Youths Should be Treated for Obesity Much Earlier to Prevent Diabetes Posted: Wednesday, September 13, 2006

Watchful waiting when faced with overweight preschoolers and elementary school children is poor pediatric practice.

Steroids Trial Beats Diabetes Blindness Posted: Wednesday, September 13, 2006

Australian research has proven the effectiveness of a steroid treatment for a type of diabetic blindness.

Adherence to Preventive Medications Reduces Risk of Diabetes Posted: Wednesday, September 13, 2006

Participants who were compliant had a 38.2% reduced risk of developing diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.